Skip to main content

Winton Group Ltd

SEC CIK
0001612063
Latest filing
Aug 7, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Winton Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of BMRN by Winton Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−18,720−100.0%Sold outHolders
Q4 202518,720$1.11M<0.1%−104,754−84.8%ReducedHolders
Q3 2025123,474$6.69M0.3%+119,267+2,835.0%AddedHolders
Q2 20254,207$231.3K<0.1%−12,734−75.2%ReducedHolders
Q1 202516,941$1.20M0.1%+267+1.6%AddedHolders
Q4 202416,674$1.10M0.1%−4,639−21.8%ReducedHolders
Q3 202421,313$1.50M0.1%+15,125+244.4%AddedHolders
Q2 20246,188$509.5K<0.1%+6,188NewHolders
Q4 20230$00.0%−20,712−100.0%Sold outHolders
Q3 202320,712$1.83M0.2%+16,494+391.0%AddedHolders
Q2 20234,218$365.6K<0.1%−16,749−79.9%ReducedHolders
Q1 202320,967$2.04M0.1%+1,612+8.3%AddedHolders
Q4 202219,355$2.00M0.1%−7,494−27.9%ReducedHolders
Q3 202226,849$2.28M0.1%−8,504−24.1%ReducedHolders
Q2 202235,353$2.93M0.2%+23,649+202.1%AddedHolders
Q1 202211,704$902.0K<0.1%+2,164+22.7%AddedHolders
Q4 20219,540$843.0K0.1%−8,515−47.2%ReducedHolders
Q3 202118,055$1.40M0.1%+6,098+51.0%AddedHolders
Q2 202111,957$998.0K0.1%+637+5.6%AddedHolders
Q1 202111,320$855.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.